Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Volume-linked Tender and Generic Substitution Put MNCs to Test in China Despite ...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on national level volume-linked centralized drug purchase te... (12/31/2018)
   
China's Patent Flood Stifles Foreign Filer Freedom (1/17/2019)
China's Biopharmas Buffeted by Clashing Market Dynamics (1/16/2019)
The Chinese Stomach Cancer Market (1/10/2019)
New Developments in the Fourth Amendment of the Patent Law of the PRC (1/10/2019)
How Health Care Data and Lax Rules Help China Prosper in AI (1/8/2019)
NYT: U.S. Officials Warn Health Researchers over China (1/8/2019)
NYT: China’s Health Care Crisis (1/8/2019)
Can China's R&D Sector Shake Its Reputational Issues in 2019? (1/4/2019)
Volume-linked Tender and Generic Substitution Put MNCs to Test in China Despite Surge of New Drug Approvals (12/31/2018)
China Biotech: Six Things to Watch in 2019 (12/24/2018)
New Pfizer CEO's Top Priorities? Think China and Pipeline, Not Deals (12/18/2018)
China's Win-At-All-Costs Approach Suggests It Will Follow Its Own Dangerous Path in Biomedicine (12/18/2018)
Gilead Sciences Takes Off in China with Commitment to Cure Hepatitis (12/18/2018)
China's Patent Linkage Plan in Serious Doubt (12/18/2018)
Hong Kong Could Become A Hub for Genetics-Based Drugs Discovery. Just One Hitch - Would Beijing Stand in Way? (12/12/2018)
The State Council Issues Trial Plan for ...  (1/17/2019)
Boehringer Ingelheim Expands Biopharma C...  (1/17/2019)
China to Focus Corruption Fighting on He...  (1/17/2019)
AstraZeneca to Promote Luye Pharma's Cho...  (1/16/2019)
Shanghai Introduces Point System for Phy...  (1/16/2019)
Bio-Thera Partners with Cipla to Market ...  (1/16/2019)
Ironwood Pharma Announces IBS Drug Linze...  (1/16/2019)
Novo Nordisk Pharmatech A/S signs Asia P...  (1/16/2019)
Chinese mAb Market to Grow 13.7% CAGR be...  (1/16/2019)
SMEI Predicts Four China Healthcare Sect...  (1/15/2019)
Bayer Files IND of Loxo’s Novel Antican...  (1/15/2019)
China Pledges to Advance Poverty Allevia...  (1/15/2019) (free)
Celltrion Set to Enter Chinese Pharmaceu...  (1/15/2019)
A New Scandal Involving Expired Polio Va...  (1/15/2019)
Adagene Announces Collaboration for Disc...  (1/15/2019)
Pfizer and GSK Announce JV to Create a Global Consumer H...
Top 25 Global Pharmaceutical Companies by Market Cap 201...
CANbridge Receives IND Approval to Commence CAN008 Phase...
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Chinese mAb Market to Grow 13.7% CAGR between 2017 and 2022
SMEI Predicts Four China Healthcare Sector Trends in 2019
IQVIA: Chinese Retail Pharmacy Market Growth Slowed in MAT Q3/2...
IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q3/2018
NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
Boehringer Ingelheim Expands Biopharma Commercial Manufactur...
AstraZeneca to Promote Luye Pharma's Cholesterol TCM in Main...
Bio-Thera Partners with Cipla to Market Key Cancer Biosimila...
Ironwood Pharma Announces IBS Drug Linzess Approval in China...
Bayer Files IND of Loxo’s Novel Anticancer Vitrakvi in Chin...
Shanghai Introduces Point System for Physician Irregular...
A New Scandal Involving Expired Polio Vaccine under Inve...
NMPA Holds 2018 National Drug Regulation Conference
CDE Seeks Comments on Draft ICH Guideline E8 and Q3C(R7)...
Snapshot of 404 Drugs Granted Priority Review from 2016
Hogan Lovells: Pharma Companies May Benefit from Proposed Pa...
SAMR Fines Two More API Companies for Monopolistic Violation...
SAMR to Raise Compensation for Flawed Products Endangering L...
Draft Patent Law Amendment Under First Review by the NPC (wi...
NPC Reviews Draft Foreign Investment Law to Ban Forced Techn...
Novo Nordisk Pharmatech A/S signs Asia Pacific distribut...
Trade Bodies Warns API Supply Chain Disruptions from Chi...
India Seeks to Reduce Reliance on Chinese Pharma Imports...
USFDA Warns Zhejiang Huahai for Failure to Detect Valsar...
Chinese Heparin Maker Yibin Lihao Bio Banned by EMA over...
Chinese Researchers Made Progress with Reportedly New Ge...
Ascletis' IND Filing for Its Third HCV Drug ASC21 Accept...
Luye Pharma Files NDA for Risperidone ER Microspheres fo...
JHL Biotech Announces First Patient Randomized in the Ph...
NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt (Sinti...
The State Council Issues Trial Plan for Nationally-Organ...
China to Focus Corruption Fighting on Healthcare and Edu...
China Pledges to Advance Poverty Alleviation in Healthca...
NHC: 17 Anticancers with Negotiated BMI Inclusion in Mos...
SMIA Hosts National Medical Insurance Working Conference...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Official and Executive Moves
Recent Executive Moves
Call for Speakers - Upcoming Pharma China Annual Forum 2...
Upcoming Event: Pediatrics Congress 2019
Upcoming Event: 12th international conference on Vascula...
Upcoming Event: PHARM Connect Congress 2019
China to Launch New Tech Bourse in Shanghai
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Publishes the China Phar...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links